1. Risk Factors for Coronary Heart Disease

   • Stephen B. Hulley

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 1 - 4

2. Experiences from Hypertension Trials — Effects on Stroke and Coronary Heart Disease

   • Göran Berglund

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 5 - 8

3. Experiences from Hypertension Trials

   • Ola Samuelsson

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 9 - 20

4. Lowering Lipids and the Genesis of Hypertension

   • Lars-Göran Ekelund

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 21 - 21

5. Diabetes and Atherosclerosis

   • George Steiner

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 22 - 26

6. Cholesterol Reduction and Coronary Artery Disease

   • Matti J. Tikkanen
   • Kalevi Pyörälä

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 27 - 31

7. Helsinki Heart Study

   • Jussi K. Huttunen
   • M. Heikki Frick
   • Helsinki Heart Study Group

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 32 - 36

8. Regression of Coronary Atherosclerosis

   • David D. Waters
   • Jacques Lespérance

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 37 - 42

9. Discussion Section 1

   Section 1: Epidemiology and Intervention: A Perspective on the Risk Factors 23 October 2012 Pages: 43 - 45

10. Interaction of Lipoproteins with the Artery Wall

    • Neville Woolf

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 46 - 50

11. Normal and Pathological Lipoprotein Metabolism

    • Gilbert R. Thompson

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 51 - 54

12. The Lipoprotein Receptor Concept

    • David W. Bilheimer

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 55 - 62

13. An Overview of Lipid-Lowering Drugs

    • D. Roger Illingworth

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 63 - 71

14. Mechanism of Action and Biological Profile of HMG CoA Reductase Inhibitors

    • Eve E. Slater
    • James S. MacDonald

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 72 - 82

15. HMG CoA Reductase Inhibitors

    • J. Findlay Walker

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 83 - 86

16. Clinical Experience with Simvastatin Compared with Cholestyramine

    • D. W. Erkelens
    • M. G. A. Baggen
    • M. J. T. M. Mol

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 87 - 92

17. Discussion Section 2

    Section 2: Lipoprotein Metabolism: Treatment of Hypercholesterolaemia 23 October 2012 Pages: 93 - 94

18. Population and Individual Strategies for the Prevention of Coronary Heart Disease

    • Barry Lewis

    Section 3: Future Strategies 23 October 2012 Pages: 95 - 99

19. The US National Cholesterol Education Program

    • Stephen B. Hulley

    Section 3: Future Strategies 23 October 2012 Pages: 100 - 104

20. Strategies for Dietary and Anti-Smoking Advice

    • Ingvar Hjermann

    Section 3: Future Strategies 23 October 2012 Pages: 105 - 109

21. The Future of Pharmacological Therapy for Risk Factor Reduction

    • Lennart Hansson

    Section 3: Future Strategies 23 October 2012 Pages: 110 - 114

22. The Future of Pharmacological Therapy for Risk Factor Reduction

    • Anders G. Olsson
    • Jörgen Mölgaard

    Section 3: Future Strategies 23 October 2012 Pages: 115 - 120

23. Discussion Section 3

    Section 3: Future Strategies 23 October 2012 Pages: 121 - 122